Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The incident information was reviewed; however, the product was not returned to abbott vascular for analysis.It should be noted that pta, armada 35 / armada 35 ll, global, ce, costa rica instructions for use states: the device is intended for dilatation of lesions in the renal, iliac, femoral, popliteal, tibial, and peroneal arteries.In this case, use of the armada 35 in the arteriovenous fistula did not cause or contribute to the reported balloon rupture.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot.The device was prepped prior to use without any leak or ruptures noted, which would suggest that the device was not damaged prior to use.The investigation determined the reported balloon rupture appears to be related to circumstances of the procedure.Based on the reported information, the balloon ruptured during the second inflation at rated bust pressure of 14 atmospheres.It is likely the balloon became compromised and/or damaging against the anatomy resulting in the balloon rupture.The reported patient effects appear to be related to circumstances of the procedure as the perforation was surgically repaired.There is no indication of a product quality issue with respect to manufacture, design or labeling.It was initially reported that the device would be returned for analysis.Subsequent information revealed that the device was discarded and is not available for evaluation.
|